WO2006024949A3 - Controlled release dosage forms combining immediate release and sustained release of low-solubility drug - Google Patents
Controlled release dosage forms combining immediate release and sustained release of low-solubility drug Download PDFInfo
- Publication number
- WO2006024949A3 WO2006024949A3 PCT/IB2005/002825 IB2005002825W WO2006024949A3 WO 2006024949 A3 WO2006024949 A3 WO 2006024949A3 IB 2005002825 W IB2005002825 W IB 2005002825W WO 2006024949 A3 WO2006024949 A3 WO 2006024949A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- release
- low
- dosage forms
- solubility drug
- forms combining
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0514416-7A BRPI0514416A (en) | 2004-08-31 | 2005-08-19 | controlled release dosage forms combining immediate release and controlled release of a low solubility drug |
CA002578474A CA2578474A1 (en) | 2004-08-31 | 2005-08-19 | Controlled release dosage forms combining immediate release and sustained release of low-solubility drug |
JP2007529035A JP2008511609A (en) | 2004-08-31 | 2005-08-19 | Controlled release dosage forms combining rapid and sustained release of low-solubility drugs |
EP05782784A EP1789022A2 (en) | 2004-08-31 | 2005-08-19 | Controlled release dosage forms combining immediate release and sustained release of low-solubility drug |
MX2007002375A MX2007002375A (en) | 2004-08-31 | 2005-08-19 | Controlled release dosage forms combining immediate release and sustained release of low-solubility drug. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60595504P | 2004-08-31 | 2004-08-31 | |
US60/605,955 | 2004-08-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006024949A2 WO2006024949A2 (en) | 2006-03-09 |
WO2006024949A3 true WO2006024949A3 (en) | 2006-05-04 |
Family
ID=35746910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2005/002825 WO2006024949A2 (en) | 2004-08-31 | 2005-08-19 | Controlled release dosage forms combining immediate release and sustained release of low-solubility drug |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1789022A2 (en) |
JP (1) | JP2008511609A (en) |
BR (1) | BRPI0514416A (en) |
CA (1) | CA2578474A1 (en) |
MX (1) | MX2007002375A (en) |
WO (1) | WO2006024949A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7842312B2 (en) | 2005-12-29 | 2010-11-30 | Cordis Corporation | Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same |
JP5527921B2 (en) * | 2006-12-22 | 2014-06-25 | エスエス製薬株式会社 | Oral solid composition concealing bitterness |
UY34403A (en) | 2011-10-21 | 2013-05-31 | Takeda Pharmaceutical | SUSTAINED RELEASE PREPARATION |
JPWO2014171542A1 (en) * | 2013-04-19 | 2017-02-23 | 武田薬品工業株式会社 | Controlled release formulation |
SG11201805810PA (en) * | 2015-09-01 | 2018-08-30 | Wellesley Pharmaceuticals Llc | Extended, delayed and immediate release formulation method of manufacturing and use thereof |
JP7152481B2 (en) | 2017-07-10 | 2022-10-12 | ジェル キャップ テクノロジーズ,エルエルシー | Dual release capsule dosage form and method, apparatus and system for manufacturing same |
GB201719769D0 (en) * | 2017-11-28 | 2018-01-10 | Cronin 3D Ltd | Analytical device and methods of use |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6046177A (en) * | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
EP1027887A2 (en) * | 1999-02-10 | 2000-08-16 | Pfizer Products Inc. | Matrix controlled release device |
US20020009494A1 (en) * | 1997-08-11 | 2002-01-24 | Curatolo William J. | Solid pharmaceutical dispersions with enhanced bioavailability |
WO2004037190A2 (en) * | 2002-10-25 | 2004-05-06 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
WO2005020929A2 (en) * | 2003-09-02 | 2005-03-10 | Imran Ahmed | Sustained release dosage forms of ziprasidone |
-
2005
- 2005-08-19 CA CA002578474A patent/CA2578474A1/en not_active Abandoned
- 2005-08-19 JP JP2007529035A patent/JP2008511609A/en not_active Withdrawn
- 2005-08-19 MX MX2007002375A patent/MX2007002375A/en unknown
- 2005-08-19 EP EP05782784A patent/EP1789022A2/en not_active Withdrawn
- 2005-08-19 BR BRPI0514416-7A patent/BRPI0514416A/en not_active IP Right Cessation
- 2005-08-19 WO PCT/IB2005/002825 patent/WO2006024949A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6046177A (en) * | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
US20020009494A1 (en) * | 1997-08-11 | 2002-01-24 | Curatolo William J. | Solid pharmaceutical dispersions with enhanced bioavailability |
EP1027887A2 (en) * | 1999-02-10 | 2000-08-16 | Pfizer Products Inc. | Matrix controlled release device |
WO2004037190A2 (en) * | 2002-10-25 | 2004-05-06 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
WO2005020929A2 (en) * | 2003-09-02 | 2005-03-10 | Imran Ahmed | Sustained release dosage forms of ziprasidone |
Also Published As
Publication number | Publication date |
---|---|
WO2006024949A2 (en) | 2006-03-09 |
JP2008511609A (en) | 2008-04-17 |
EP1789022A2 (en) | 2007-05-30 |
MX2007002375A (en) | 2007-04-23 |
BRPI0514416A (en) | 2008-06-10 |
CA2578474A1 (en) | 2006-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006024949A3 (en) | Controlled release dosage forms combining immediate release and sustained release of low-solubility drug | |
EP1839121A4 (en) | Systems and methods for managing the development and manufacturing of a drug | |
IL180883A0 (en) | Dosage forms with an enterically coated core tablet | |
AU2003221770A1 (en) | Controlled release transdermal drug delivery | |
IL179140A0 (en) | Antibody drug conjuates and methods | |
WO2005048923A3 (en) | Extended release venlafaxine formulation | |
WO2006060547A3 (en) | Systems and methods for intra-oral drug delivery | |
HK1106459A1 (en) | Method of assembly of drug delivery devices | |
HK1126671A1 (en) | Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same | |
IL216104A0 (en) | Coated drug delivery formulations | |
AU2007240758A8 (en) | Magnetic targeting and sequestering of therapeutic formulations | |
PL1655026T3 (en) | Solid pharmaceutical formulations comprising diacereine and meloxicam | |
AU2003220472A1 (en) | Modified release dosage form with two cores | |
EP1791506A4 (en) | Methods of device-assisted drug delivery | |
AU2003261067A1 (en) | Modified release ketoprofen dosage form | |
WO2012156997A3 (en) | Multi-particulate pharmaceutical composition | |
ZA200705080B (en) | Aminocarboxylic acid derivative and medicinal use thereof | |
GB0406048D0 (en) | Drug formulations | |
AU2002231176A1 (en) | Sustained release drug delivery devices with coated drug cores | |
GB0426342D0 (en) | Coupler capable of releasing development accelerator | |
AU2002231162A1 (en) | Sustained release drug delivery devices with prefabricated permeable plugs | |
AU2004900501A0 (en) | A Party Game | |
AU2004903160A0 (en) | ARCHERY SIGHT - MAGNIFIED and Non - Magnified - O ring Aperture | |
AU2004901550A0 (en) | Solid core phacoemulsification needle | |
AU2004900098A0 (en) | Flash and Sound Emitting Diversion Grenade |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005782784 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007529035 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/002375 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2578474 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2005782784 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0514416 Country of ref document: BR |